October 6, 2022

Medical Trend

Medical News and Medical Resources

FDA restricts Johnson & Johnson COVID-19 vaccine due to risks of blood clots

FDA restricts Johnson & Johnson COVID-19 vaccine due to risks of blood clots



 

FDA restricts Johnson & Johnson COVID-19 vaccine due to risks of blood clots

On May 05,  U.S. Food and Drug Administration (FDA) announced on the same day that they would limit the emergency use authorization of Johnson & Johnson’s COVID-19 vaccine because it May cause rare and dangerous thrombocytopenic blood clots in recipients.

With immediate effect, Johnson & Johnson’s COVID-19 vaccine in the United States will be limited to adults over the age of 18 who cannot receive other vaccines.

 

 

FDA restricts Johnson & Johnson COVID-19 vaccine due to risks of blood clots

Screenshot from CNN website

 

 

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the center has been monitoring the incidence of thrombocytopenic blood clots following Johnson & Johnson’s COVID-19 vaccine and is updating the emergency use authorization through its “safety surveillance system.” .

 

Marks said that the FDA’s move this time reflects the power of the “safety surveillance system” and also shows that they are determined to use science and data to guide action.

 

FDA restricts Johnson & Johnson COVID-19 vaccine due to risks of blood clots

 

CNN confirmed to the FDA that this restriction also applies to booster shots.

 

The FDA believes that for certain groups of people, the risks of J&J’s COVID-19 vaccine already outweigh the benefits, but they can still receive J&J’s COVID-19 vaccine for the following groups: Severe allergic reaction to Pfizer or Moderna’s mRNA COVID-19 vaccine Those who have personal doubts about the mRNA COVID-19 vaccine, if they do not receive the Johnson & Johnson COVID-19 vaccine, they will not be vaccinated; those who cannot receive the mRNA COVID-19 vaccine.

 

According to the U.S. Centers for Disease Control and Prevention (CDC), more than 18.7 million doses of Johnson & Johnson’s COVID-19 vaccine have been administered in the United States. Among those in the U.S. who have been fully vaccinated, 7.7% of the people who received the Johnson & Johnson vaccine were vaccinated.

 

According to the FDA’s statistics as of March 18, they have confirmed 60 cases of thrombocytopenic blood clots after vaccination with Johnson & Johnson’s COVID-19 vaccine, including 9 deaths.

 

 

Should Johnson & Johnson COVID-19 vaccine be used for booster?

 

 

 

FDA restricts Johnson & Johnson COVID-19 vaccine due to risks of blood clots

(source:internet, reference only)


Disclaimer of medicaltrend.org